Back
Cidara Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
61
CDTX
Cidara Therapeutics
Last Price:
$23.26
Seasonality Move:
12.86%
7 Day Trial
ALL ACCESS PASS
$
7
How to Turn the AI Energy Crisis into BIG Profits
And investors who move now into one technology could make a whole lot of money.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing slight buying pressure.
Cidara Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 22.33 | Buy |
| 20-day SMA: | 21.13 | Buy |
| 50-day SMA: | 16.16 | Buy |
| 200-day SMA: | 13.73 | Buy |
| 8-day EMA: | 22.24 | Buy |
| 20-day EMA: | 20.71 | Buy |
| 50-day EMA: | 17.55 | Buy |
| 200-day EMA: | 14.73 | Buy |
Cidara Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.89 | Buy |
| Relative Strength Index (14 RSI): | 63.28 | Buy |
| Chaikin Money Flow: | 65703 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.24 - 22.76) | Buy |
| Bollinger Bands (100): | (10.09 - 17.81) | Buy |
Cidara Therapeutics Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Cidara Therapeutics Stock
Is Cidara Therapeutics Stock a Buy?
-
Cidara Therapeutics share price is 23.22 while CDTX 8-day simple moving average is 22.33, which is a Buy signal.
-
The stock price of CDTX is 23.22 while Cidara Therapeutics 20-day SMA is 21.13, which makes it a Buy.
-
Cidara Therapeutics 50-day simple moving average is 16.16 while CDTX share price is 23.22, making it a Buy technically.
-
CDTX stock price is 23.22 and Cidara Therapeutics 200-day simple moving average is 13.73, creating a Buy signal.
CDTX Technical Analysis vs Fundamental Analysis
Buy
61
Cidara Therapeutics (CDTX)
is a Buy
Is Cidara Therapeutics a Buy or a Sell?
-
Cidara Therapeutics stock is rated a BuyThe current Cidara Therapeutics [CDTX] share price is $23.22. The Score for CDTX is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
Cidara Therapeutics Stock Info
Market Cap:
254M
Price in USD:
23.22
Share Volume:
148.4K
Cidara Therapeutics 52-Week Range
52-Week High:
24.99
52-Week Low:
10.00
Buy
61
Cidara Therapeutics (CDTX)
is a Buy
Cidara Therapeutics Share Price Forecast
-
What is the Cidara Therapeutics stock price today?The Cidara Therapeutics stock price is 23.22 USD today.
-
Will CDTX stock go up or go down?Cidara Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Cidara Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cidara Therapeutics is not overvalued.
Is Cidara Therapeutics Stock a Buy?
-
Cidara Therapeutics share price is 23.22 while CDTX 8-day exponential moving average is 22.24, which is a Buy signal.
-
The stock price of CDTX is 23.22 while Cidara Therapeutics 20-day EMA is 20.71, which makes it a Buy.
-
Cidara Therapeutics 50-day exponential moving average is 17.55 while CDTX share price is 23.22, making it a Buy technically.
-
CDTX stock price is 23.22 and Cidara Therapeutics 200-day simple moving average is 14.73, creating a Buy signal.
Fundamental Analysis of Cidara Therapeutics
Is Cidara Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $2.22 per share, a decrease next quarter of $0.00 per share, a decrease this year of $16.29 per share, and an increase next year of $13.86 per share.
Technical Analysis of Cidara Therapeutics
Should I short Cidara Therapeutics stock?
-
CDTX Moving Average Covergence Divergence (MACD) indicator is 1.89, suggesting Cidara Therapeutics is a Buy
-
Cidara Therapeutics Relative Strength Index (RSI) is 63.28, which suggest Cidara Therapeutics is overbought
-
The Bollinger Bands (25) for Cidara Therapeutics is (17.24 - 22.76), which suggest Cidara Therapeutics is a Buy
-
The Bollinger Bands (100) for Cidara Therapeutics is (10.09 - 17.81), which suggest Cidara Therapeutics is a Buy
* Cidara Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.